Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page’s documentation/versioning. It does not modify the study details or other critical content.
    Difference
    0.1%
    Check dated 2026-06-08T03:56:30.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page footer now shows a newer revision label (v3.5.4), indicating a minor build update. This change does not modify the study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-05-17T10:05:42.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page’s footer revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a change in the site build rather than any study details.
    Difference
    0.1%
    Check dated 2026-04-25T16:56:28.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new release version v3.5.2 was added and the previous v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-18T12:56:51.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a citation to iRECIST guidelines in the references and removed the corresponding erratum note.
    Difference
    0.1%
    Check dated 2026-04-04T05:08:02.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the page. Revision: v3.4.3 was removed from the page.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:12.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.